Skip to content
Wayam AI
HealthcareQuality & ComplianceRepresentative scenario

End to End Requirements to Design Verification Test Traceability

A neurotechnology enterprise developing an implantable neurostimulator and wireless patient controller for chronic pain management.

Run on Tatvam · Design Risk & FMEA

An unbroken chain from requirement through design to verification

The challenge

    01

    Regulatory standards mandated complete bidirectional traceability from clinical hazards to design inputs, risk controls, and verification test protocols.

    02

    Traceability was maintained in static Word tables, where updating a single requirement required manually editing 40 separate cross reference links.

    03

    During a pre submission audit, auditors discovered 12 unverified risk control mitigations that lacked documented test results, jeopardizing FDA submission.

How Tatvam solves it

    01

    Bidirectional Digital Traceability Matrix

    Tatvam establishes live bidirectional links between Clinical Hazards, Design Inputs, DFMEA Line Items, Risk Controls, and Test Protocols.

    02

    Automated Traceability Gap Detection

    Continuously scans the traceability graph, instantly flagging any risk mitigation that lacks an approved verification test procedure.

    03

    Direct Test Management Tool Integration

    Integrates with Jira, Azure DevOps, and test execution tools to pull live pass/fail test results directly into the DFMEA.

    04

    Impact Analysis for Test Failures

    Highlights which specific clinical risk controls are compromised whenever a design verification bench test fails.

    05

    Audit Ready Traceability Matrix Export

    Generates comprehensive, formatted, and clickable Traceability Matrices compliant with FDA guidance in seconds.

The outcome

complete bidirectional traceability achieved across 1,800
0%complete bidirectional traceability achieved across 1,800
reduced regulatory submission audit preparation labor
0%reduced regulatory submission audit preparation labor
  • 100% complete bidirectional traceability achieved across 1,800 design inputs, risk controls, and test protocols.

  • Eliminated all traceability gaps and unverified risk mitigations prior to regulatory filing.

  • Reduced regulatory submission audit preparation labor by 85%.

Representative scenario: a modelled industry situation showing how this accelerator applies. Figures are projections, not a named client result.

Capabilities used

Every accelerator is assembled from the same capability layer, so a workflow you adopt here shares its foundation with the rest of the portfolio.

Bring us the version of this that you actually have.

Every engagement is fixed-scope and outcome-guaranteed. The scoping conversation starts with your systems, not with a template.